BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
2/12/16 Pfizer (PFE) Biosimilar Infliximab (Pfizer) for Rheumatoid Arthritis (RA) Subscribers Only Subscribers Only Subscribers Only
2/12/16 Biogen (BIIB) Tysabri for Multiple Sclerosis (MS) Subscribers Only Subscribers Only Subscribers Only
2/12/16 Amgen (AMGN) Kyprolis for Multiple Myeloma (MM) Subscribers Only Subscribers Only Subscribers Only
2/12/16 Celsion (CLSN) GEN-1 for Ovarian Cancer Subscribers Only Subscribers Only Subscribers Only
2/12/16 Clovis Oncology (CLVS) Rociletinib for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
02/14/16 Subscribers Only Subscribers Only Trial Data - Top-Line Results
02/14/16 Subscribers Only Subscribers Only Trial Data - Other
02/14/16 Subscribers Only Subscribers Only Trial Data - Other
Now - 02/15/16 Subscribers Only Subscribers Only Regulatory - IND Filing
Now - 02/15/16 Subscribers Only Subscribers Only Trial Announcement - Initiation